These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9656971)

  • 1. PET imaging studies in drug abuse.
    Fowler JS; Volkow ND
    J Toxicol Clin Toxicol; 1998; 36(3):163-74. PubMed ID: 9656971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron emission tomography and single-photon emission computed tomography in substance abuse research.
    Volkow ND; Fowler JS; Wang GJ
    Semin Nucl Med; 2003 Apr; 33(2):114-28. PubMed ID: 12756644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET imaging in clinical drug abuse research.
    Gatley SJ; Volkow ND; Wang GJ; Fowler JS; Logan J; Ding YS; Gerasimov M
    Curr Pharm Des; 2005; 11(25):3203-19. PubMed ID: 16250850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addiction and imaging of the living human brain.
    Gatley SJ; Volkow ND
    Drug Alcohol Depend; 1998; 51(1-2):97-108. PubMed ID: 9716933
    [No Abstract]   [Full Text] [Related]  

  • 5. Human brain imaging and substance abuse.
    Lingford-Hughes A
    Curr Opin Pharmacol; 2005 Feb; 5(1):42-6. PubMed ID: 15661624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET imaging for addiction medicine: From neural mechanisms to clinical considerations.
    Wiers CE; Cabrera E; Skarda E; Volkow ND; Wang GJ
    Prog Brain Res; 2016; 224():175-201. PubMed ID: 26822359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography molecular imaging of dopaminergic system in drug addiction.
    Hou H; Tian M; Zhang H
    Anat Rec (Hoboken); 2012 May; 295(5):722-33. PubMed ID: 22467195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging neurotransmitter release by drugs of abuse.
    Martinez D; Narendran R
    Curr Top Behav Neurosci; 2010; 3():219-45. PubMed ID: 21161755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroimaging in drug abuse.
    Lindsey KP; Gatley SJ; Volkow ND
    Curr Psychiatry Rep; 2003 Oct; 5(5):355-61. PubMed ID: 13678555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predisposition to addiction: pharmacokinetics, pharmacodynamics, and brain circuitry.
    Kalivas PW
    Am J Psychiatry; 2003 Jan; 160(1):1-2. PubMed ID: 12505792
    [No Abstract]   [Full Text] [Related]  

  • 11. Targeting the treatment of drug abuse with molecular imaging.
    Schiffer WK; Liebling CN; Patel V; Dewey SL
    Nucl Med Biol; 2007 Oct; 34(7):833-47. PubMed ID: 17921034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacology of mood-altering drugs of abuse.
    Carr LA
    Prim Care; 1993 Mar; 20(1):19-31. PubMed ID: 8464940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and cellular basis of addiction.
    Nestler EJ; Aghajanian GK
    Science; 1997 Oct; 278(5335):58-63. PubMed ID: 9311927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging brain function in animals to understand drugs of abuse and potential pharmacotherapies.
    Piercey MF
    NIDA Res Monogr; 1994; 138():25-40. PubMed ID: 7603543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychiatric disorders: investigation of schizophrenia and substance abuse.
    Volkow ND; Fowler JS
    Semin Nucl Med; 1992 Oct; 22(4):254-67. PubMed ID: 1439871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The addicted human brain: insights from imaging studies.
    Volkow ND; Fowler JS; Wang GJ
    J Clin Invest; 2003 May; 111(10):1444-51. PubMed ID: 12750391
    [No Abstract]   [Full Text] [Related]  

  • 17. An overview of gamma-hydroxybutyric acid: pharmacodynamics, pharmacokinetics, toxic effects, addiction, analytical methods, and interpretation of results.
    Andresen H; Aydin BE; Mueller A; Iwersen-Bergmann S
    Drug Test Anal; 2011 Sep; 3(9):560-8. PubMed ID: 21381220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonhuman primate positron emission tomography neuroimaging in drug abuse research.
    Howell LL; Murnane KS
    J Pharmacol Exp Ther; 2011 May; 337(2):324-34. PubMed ID: 21317354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET and SPECT in drug and substance abuse.
    Mena JC; Cuellar H; Vargas D; Riascos R
    Top Magn Reson Imaging; 2005 Jun; 16(3):253-6. PubMed ID: 16340650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional studies in substance abuse: imaging and beyond.
    Levin JM; Kaufman MJ
    J Nucl Med; 1995 Jul; 36(7):1298-300. PubMed ID: 7790959
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.